サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1349403

単球活性化試験市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年から2031年

Monocyte Activation Test Market (Product Type: MAT Kits and Reagents; and Source: PBMC Based and Cell Line Based) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
単球活性化試験市場：世界の業界分析、規模、シェア、成長、動向、予測、2023年から2031年
出版日: 2023年07月25日
発行: Transparency Market Research
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

単球活性化試験市場- レポートの範囲

世界の単球活性化試験市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とし、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、単球活性化試験市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 6,070万米ドル
2031年の市場価値 3億530万米ドル
CAGR19.8%

このレポートは、世界の単球活性化試験市場の競合情勢を詳しく掘り下げています。世界の単球活性化試験市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の単球活性化試験市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • パイロジェンテストの進歩
  • ヘルスケア業界の概要
  • COVID-19感染症パンデミックによる業界への影響（バリューチェーンと短期・中期・長期的な影響）
  • 技術の進歩

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：製品タイプ別、2017-2031
    • MATキット
    • 試薬
  • 市場魅力度分析：製品タイプ別

第7章 世界市場の分析と予測：原料別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：原料別、2017-2031
    • PBMCベース
    • 細胞株ベース
  • 市場の魅力分析：原料別

第8章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：用途別、2017-2031
    • 医薬品開発
    • ワクチン開発
    • 医療機器の試験
    • その他（調査等）
  • 市場魅力分析：用途別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な発見/開発
  • 市場金額予測：エンドユーザー別、2017-2031
    • 製薬産業
    • バイオテクノロジー産業
    • 医療機器産業
    • その他（CRO、学術研究機関等）
  • 市場魅力度分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場魅力度

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2021年）
  • 企業プロファイル
    • Merck KGaA
    • Thermo Fisher Scientific
    • Charles River Laboratories International, Inc.
    • Sanquin
    • Microcoat Biotechnologie GmbH
    • SOLVIAS AG
    • Lonza Group
    • Becton, Dickinson and Company
図表

List of Tables

  • Table 01: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 03: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Monocyte Activation Test Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 09: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 14: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 19: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 24: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 29: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Monocyte Activation Test Market Size (US$ Mn) and Distribution, by Region, 2022 and 2031
  • Figure 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 03: Global Monocyte Activation Test Market Value Share, by Product Type (2022)
  • Figure 04: Global Monocyte Activation Test Market Value Share, by Source (2022)
  • Figure 05: Global Monocyte Activation Test Market Value Share, by Application (2022)
  • Figure 06: Global Monocyte Activation Test Market Value Share, by End-user (2022)
  • Figure 07: Global Monocyte Activation Test Market Value Share, by Product Type, 2022 and 2031
  • Figure 08: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by MAT Kits, 2017-2031
  • Figure 09: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2017-2031
  • Figure 10: Global Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 11: Global Monocyte Activation Test Market Value Share, by Source, 2022 and 2031
  • Figure 12: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PBMC Based, 2017-2031
  • Figure 13: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cell Line Based, 2017-2031
  • Figure 14: Global Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 15: Global Monocyte Activation Test Market Value Share, by Application, 2022 and 2031
  • Figure 16: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Drug Development, 2017-2031
  • Figure 17: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vaccine Development, 2017-2031
  • Figure 18: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medical Device Testing, 2017-2031
  • Figure 19: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others (Research, etc.), 2017-2031
  • Figure 20: Global Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 21: Global Monocyte Activation Test Market Value Share, by End-user, 2022 and 2031
  • Figure 22: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical Industry, 2017-2031
  • Figure 23: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology Industry, 2017-2031
  • Figure 24: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Medical Device Industry, 2017-2031
  • Figure 25: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
  • Figure 26: Global Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 27: Global Monocyte Activation Test Market Value Share, by Region, 2022 and 2031
  • Figure 28: Global Monocyte Activation Test Market Attractiveness, by Region, 2017-2031
  • Figure 29: North America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%) 2017-2031
  • Figure 30: North America Monocyte Activation Test Market Value Share, by Country, 2022 and 2031
  • Figure 31: North America Monocyte Activation Test Market Attractiveness, by Country, 2017-2031
  • Figure 32: North America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 33: North America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 34: North America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 35: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 36: Europe Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 37: Europe Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 38: Europe Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 39: Europe Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 40: Europe Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 41: Europe Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 42: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 43: Asia Pacific Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 44: Asia Pacific Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 45: Asia Pacific Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 46: Asia Pacific Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 47: Asia Pacific Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 48: Asia Pacific Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 49: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 50: Latin America Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 51: Latin America Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 52: Latin America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 53: Latin America Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 56: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 57: Middle East & Africa Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 58: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 59: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 60: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 61: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 62: Middle East & Africa Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
目次
Product Code: TMRGL36041

Monocyte Activation Test Market - Scope of Report

TMR's report on the global monocyte activation test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global monocyte activation test market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global monocyte activation test market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the monocyte activation test market.

Market Snapshot
Market Value in 2023US$ 60.7 Mn
Market Value in 2031US$ 305.3 Mn
CAGR19.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global monocyte activation test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global monocyte activation test market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global monocyte activation test market.

The report delves into the competitive landscape of the global monocyte activation test market. Key players operating in the global monocyte activation test market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global monocyte activation test market profiled in this report.

Key Questions Answered in Global Monocyte Activation Test Market Report:

  • What is the sales/revenue generated by monocyte activation test across all regions during the forecast period?
  • What are the opportunities in the global monocyte activation test market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Monocyte Activation Test Market - Research Objectives and Research Approach

The comprehensive report on the global monocyte activation test market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global monocyte activation test market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global monocyte activation test market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Monocyte Activation Test Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Development
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Monocyte Activation Test Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Advancement in Pyrogen Tests
  • 5.2. Healthcare Industry Overview
  • 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
  • 5.4. Technological Advancements

6. Global Monocyte Activation Test Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. MAT Kits
    • 6.3.2. Reagents
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Monocyte Activation Test Market Analysis and Forecast, by Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Source, 2017-2031
    • 7.3.1. PBMC Based
    • 7.3.2. Cell Line Based
  • 7.4. Market Attractiveness Analysis, by Source

8. Global Monocyte Activation Test Market Analysis and Forecasts, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Drug Development
    • 8.3.2. Vaccine Development
    • 8.3.3. Medical Device Testing
    • 8.3.4. Others (Research, etc.)
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Monocyte Activation Test Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical Industry
    • 9.3.2. Biotechnology Industry
    • 9.3.3. Medical Device Industry
    • 9.3.4. Others (CROs, Academic & Research Institute, etc.)
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Monocyte Activation Test Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Monocyte Activation Test Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. MAT Kits
    • 11.2.2. Reagents
  • 11.3. Market Value Forecast, by Source, 2017-2031
    • 11.3.1. PBMC Based
    • 11.3.2. Cell Line Based
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Drug Development
    • 11.4.2. Vaccine Development
    • 11.4.3. Medical Device Testing
    • 11.4.4. Others (Research, etc.)
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Pharmaceutical Industry
    • 11.5.2. Biotechnology Industry
    • 11.5.3. Medical Device Industry
    • 11.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Source
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Monocyte Activation Test Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. MAT Kits
    • 12.2.2. Reagents
  • 12.3. Market Value Forecast, by Source, 2017-2031
    • 12.3.1. PBMC Based
    • 12.3.2. Cell Line Based
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Drug Development
    • 12.4.2. Vaccine Development
    • 12.4.3. Medical Device Testing
    • 12.4.4. Others (Research, etc.)
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Pharmaceutical Industry
    • 12.5.2. Biotechnology Industry
    • 12.5.3. Medical Device Industry
    • 12.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Source
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Monocyte Activation Test Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. MAT Kits
    • 13.2.2. Reagents
  • 13.3. Market Value Forecast, by Source, 2017-2031
    • 13.3.1. PBMC Based
    • 13.3.2. Cell Line Based
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Drug Development
    • 13.4.2. Vaccine Development
    • 13.4.3. Medical Device Testing
    • 13.4.4. Others (Research, etc.)
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Pharmaceutical Industry
    • 13.5.2. Biotechnology Industry
    • 13.5.3. Medical Device Industry
    • 13.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Source
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Monocyte Activation Test Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. MAT Kits
    • 14.2.2. Reagents
  • 14.3. Market Value Forecast, by Source, 2017-2031
    • 14.3.1. PBMC Based
    • 14.3.2. Cell Line Based
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Drug Development
    • 14.4.2. Vaccine Development
    • 14.4.3. Medical Device Testing
    • 14.4.4. Others (Research, etc.)
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Pharmaceutical Industry
    • 14.5.2. Biotechnology Industry
    • 14.5.3. Medical Device Industry
    • 14.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Source
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. MAT Kits
    • 15.2.2. Reagents
  • 15.3. Market Value Forecast, by Source, 2017-2031
    • 15.3.1. PBMC Based
    • 15.3.2. Cell Line Based
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Drug Development
    • 15.4.2. Vaccine Development
    • 15.4.3. Medical Device Testing
    • 15.4.4. Others (Research, etc.)
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Pharmaceutical Industry
    • 15.5.2. Biotechnology Industry
    • 15.5.3. Medical Device Industry
    • 15.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Source
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. Merck KGaA
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Charles River Laboratories International, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Sanquin
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Microcoat Biotechnologie GmbH
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. SOLVIAS AG
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Lonza Group
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Becton, Dickinson and Company
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview